| RS2131511782 |
GATA3
|
Health Risk |
Likely pathogenic |
— |
| RS2131512540 |
GDAP1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4A, Charcot-Marie-Tooth disease type 4A |
| RS2131512957 |
GDAP1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4A, Charcot-Marie-Tooth disease type 4A |
| RS2131513223 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131513660 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131513670 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131515110 |
ZNF462
|
Health Risk |
Pathogenic |
— |
| RS2131520030 |
SHOC1
|
Health Risk |
Pathogenic |
Spermatogenic failure 75, Spermatogenic failure 75 |
| RS2131520063 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy 5, Developmental and epileptic encephalopathy |
| RS2131520977 |
OPTN
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 12, Amyotrophic lateral sclerosis type 12 |
| RS2131521530 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131521557 |
GDAP1
|
Health Risk |
Likely pathogenic |
— |
| RS2131521760 |
GDAP1
|
Health Risk |
Likely pathogenic |
— |
| RS2131521957 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2131522449 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131525308 |
KRIT1
|
Health Risk |
Likely pathogenic |
— |
| RS2131525596 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131525635 |
IFT74
|
Health Risk |
Pathogenic |
— |
| RS2131525662 |
IFT74
|
Health Risk |
Pathogenic |
Multiple Morphological Anomalies of Sperm Flagella (MMAF), Spermatogenic failure 58 |
| RS2131526298 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131526402 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131527403 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131528253 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131528405 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131529670 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS2131530745 |
ZNF462
|
Health Risk |
Pathogenic |
— |
| RS2131535795 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131535952 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2131536069 |
STXBP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizure, Developmental and epileptic encephalopathy |
| RS2131536257 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2131536431 |
STXBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Developmental and epileptic encephalopathy |
| RS2131540817 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS2131540908 |
IFT74
|
Health Risk |
Pathogenic |
Joubert syndrome 40, Joubert syndrome 40 |
| RS2131541114 |
IFT74
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 22, Bardet-Biedl syndrome 22 |
| RS2131543392 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2131546441 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131553093 |
KCNT1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2131554631 |
POMT1
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2131554917 |
POMT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 |
| RS2131556360 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131558198 |
MCM10
|
Health Risk |
Pathogenic |
Immunodeficiency 80 with or without congenital cardiomyopathy, Fetal Cardiomyopathy |
| RS2131559197 |
CNGB3
|
Health Risk |
Pathogenic |
— |
| RS2131559324 |
CNGB3
|
Health Risk |
Pathogenic |
— |
| RS2131561276 |
STXBP1
|
Health Risk |
Likely pathogenic |
— |
| RS2131561363 |
STXBP1
|
Health Risk |
Pathogenic |
— |
| RS2131563546 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS2131565717 |
CNGB3
|
Health Risk |
Pathogenic |
— |
| RS2131565806 |
CNGB3
|
Health Risk |
Pathogenic |
— |
| RS2131577612 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS2131577839 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131579842 |
MCM10
|
Health Risk |
Pathogenic |
Immunodeficiency 80 with or without congenital cardiomyopathy, Immunodeficiency 80 with or without congenital cardiomyopathy |
| RS2131580177 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131580291 |
CNGB3
|
Health Risk |
Pathogenic |
— |
| RS2131581257 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS2131582838 |
CNGB3
|
Health Risk |
Pathogenic |
— |
| RS2131585371 |
CNGB3
|
Health Risk |
Pathogenic |
— |
| RS2131587158 |
VPS13A
|
Health Risk |
Likely pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS2131588122 |
POMT1
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2K |
| RS2131589934 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS2131591339 |
PAX5
|
Health Risk |
Likely pathogenic |
Acute lymphoid leukemia, Acute lymphoid leukemia |
| RS2131594360 |
CNGB3
|
Health Risk |
Pathogenic |
— |
| RS2131597459 |
CNGB3
|
Health Risk |
Pathogenic |
— |
| RS2131602318 |
DOCK8
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS2131602837 |
ELN
|
Health Risk |
Likely pathogenic |
— |
| RS2131603022 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS2131604859 |
INPP5E
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2131605715 |
INPP5E
|
Health Risk |
Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS2131605763 |
INPP5E
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2131606542 |
CUBN
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2131607846 |
INPP5E
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2131608672 |
INPP5E
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2131608743 |
INPP5E
|
Health Risk |
Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS2131610068 |
MPDZ
|
Health Risk |
Pathogenic |
Hydrocephalus, nonsyndromic |
| RS2131610473 |
INPP5E
|
Health Risk |
Likely pathogenic |
Rod-cone dystrophy, Rod-cone dystrophy |
| RS2131611242 |
INPP5E
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2131614057 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS2131614102 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131614848 |
CNGB3
|
Health Risk |
Pathogenic |
— |
| RS2131614875 |
ZFHX4
|
Health Risk |
Pathogenic |
— |
| RS2131615148 |
CNGB3
|
Health Risk |
Pathogenic |
— |
| RS2131616018 |
CNGB3
|
Health Risk |
Pathogenic |
— |
| RS2131616036 |
COL27A1
|
Health Risk |
Likely pathogenic |
Steel syndrome, Steel syndrome |
| RS2131616094 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS2131616447 |
DHTKD1
|
Health Risk |
Likely pathogenic |
2-aminoadipic 2-oxoadipic aciduria, 2-aminoadipic 2-oxoadipic aciduria |
| RS2131618521 |
COL27A1
|
Health Risk |
Likely pathogenic |
Steel syndrome, Steel syndrome |
| RS2131618846 |
CNGB3
|
Health Risk |
Likely pathogenic |
— |
| RS2131618872 |
CNGB3
|
Health Risk |
Pathogenic |
— |
| RS2131618938 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS2131619089 |
CNGB3
|
Health Risk |
Pathogenic |
— |
| RS2131619700 |
NANS
|
Health Risk |
Likely pathogenic |
Spondyloepimetaphyseal dysplasia, Genevieve type |
| RS2131619961 |
INPP5E
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2131620305 |
UBAP1
|
Health Risk |
Pathogenic |
Spastic paraplegia 80, autosomal dominant |
| RS2131620438 |
INPP5E
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2131620472 |
INPP5E
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2131625525 |
WDR37
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2131627071 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS2131628148 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Tuberous sclerosis syndrome |
| RS2131628564 |
TSC1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, TSC1-related disorder |
| RS2131628647 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS2131629002 |
DHTKD1
|
Health Risk |
Pathogenic |
2-aminoadipic 2-oxoadipic aciduria, 2-aminoadipic 2-oxoadipic aciduria |